Position in AMGN
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$304,180
-$23,040 QoQ
Shares Held
840
-9.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2,543
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WEDGE CAPITAL MANAGEMENT L L P/NC holds $67,797,573 across 8 Drug Manufacturers - General names. AMGN ranks #7 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
134,579 | $33,865,459 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
528,057 | $30,426,644 | |
| 3 | JNJ |
Johnson & Johnson
|
4,295 | $1,090,801 | |
| 4 | LLY |
ELI LILLY & Co
|
764 | $916,364 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,873 | $626,180 | |
| 6 | PFE |
Pfizer Inc
|
13,423 | $323,225 | |
| 7 | AMGN |
Amgen Inc
This page
|
840 | $304,180 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,937 | $244,720 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $304,180 | 840 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $327,220 | 930 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $263,484 | 805 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $224,349 | 795 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $221,971 | 795 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $250,486 | 804 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $209,554 | 804 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $259,056 | 804 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $243,398 | 779 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $244,515 | 860 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $31,258,234 | 108,528 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $32,697,879 | 121,662 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $31,638,294 | 142,502 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $39,341,428 | 162,736 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $37,179,843 | 141,562 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $35,338,662 | 156,782 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $36,345,857 | 149,387 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $35,649,829 | 147,423 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $33,850,560 | 150,467 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $31,011,600 | 145,834 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $32,065,800 | 131,552 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $31,308,757 | 125,834 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $28,024,948 | 121,890 | Shares | Sole | 2021-01-08 | |
| 2020-09-30 | $27,683,361 | 108,921 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $33,664,297 | 142,730 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $228,882 | 1,129 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||